Skip to main navigation
Contact Us
Homepage
About Us
Senior Leadership Team
Board of Directors
Scientific Advisory Board
Our Approach
GPS Platform
Publications & Presentations
Our Pipeline
Vilastobart (anti-CTLA-4)
XTX301 (IL-12)
Expanded Access Policy
Investors & Media
Overview
Press Releases
Events & Presentations
Financials & Filings
SEC Filings
Annual Reports
Corporate Governance
Documents & Charters
Management
Board of Directors
Committee Composition
Contact the Board
Stock Information
Analyst Coverage
Investor FAQs
Email Alerts
Contact
Careers
Event Details
Xilio Therapeutics Corporate Update Call
March 28, 2024 at 8:00 AM EDT
Listen to webcast
We use cookies to help personalize your experience. For more information on how we use cookies and similar technologies, and how you can change your settings, please see our
Privacy Policy
.
Cookie Settings
Ok